Daniel Fuster | Profiles RNS

Daniel Fuster, MD, PhD

Visiting Researcher

Boston University Chobanian & Avedisian School of Medicine

Medicine

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Haque LY, Zuluaga P, Muga R, Fuster D. Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addict Sci Clin Pract. 2024 Mar 19; 19(1):19. PMID: 38504384; PMCID: PMC10949674; DOI: 10.1186/s13722-024-00448-8;

Fuster D, Zuluaga P, Muga R. Substance use disorder: Epidemiology, medical consequences and treatment. Med Clin (Barc). 2024 Jan 12. PMID: 38218656

Fuster D, Llorente C, Garcia-Calvo X, Bolao F, Zuluaga P, Hernández-Rubio A, Casado-Carbajo J, Leis A, Muga R. Fungal plasma biomarkers in patients admitted for inpatient treatment of alcohol use disorder. Alcohol Clin Exp Res (Hoboken). 2023 Aug; 47(8):1582-1589. PMID: 37364901

Zurera-Egea C, Teniente-Serra A, Fuster D, Martínez-Cáceres E, Muga R, Zuluaga P. Cytotoxic NK cells phenotype and activated lymphocytes are the main characteristics of patients with alcohol-associated liver disease. Clin Exp Med. 2023 Nov; 23(7):3539-3547. PMID: 37392250; PMCID: PMC10618338; DOI: 10.1007/s10238-023-01121-1;

Hernández-Rubio A, Sanvisens A, Barbier-Torres L, Blanes R, Miquel L, Torrens M, Rubio G, Bolao F, Zuluaga P, Fuster D, Rodríguez de Fonseca F, Farré M, Muga R. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder. Drug Alcohol Depend. 2023 Apr 01; 245:109822. PMID: 36893509

Romero-Rodríguez E, Fuster D, Pérula de Torres LÁ, Saitz R. Is clinicians' alcohol consumption associated with their preventive practices to reduce unhealthy alcohol use? A systematic review of current evidence. Alcohol Clin Exp Res. 2023 Jan; 47(1):7-17. PMID: 36773022

Hernandez A, Boigues M, Felip E, Cucurull M, Notario L, Pous A, Torres P, Benitez M, Rodriguez M, Quirant B, Romeo M, Fuster D, Moran T. Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study. Cancers (Basel). 2022 Dec 26; 15(1). PMID: 36612134; PMCID: PMC9817972; DOI: 10.3390/cancers15010137;

Domínguez-Domínguez L, Rava M, Bisbal O, Lopez-Cortés L, Portilla J, Podzamczer D, Olalla J, Fuster D, Rubio R, Jarrín I, Iribarren JA, Moreno S. Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018. BMC Infect Dis. 2022 Apr 15; 22(1):379. PMID: 35428209; PMCID: PMC9013070; DOI: 10.1186/s12879-022-07352-z;

Poyatos L, Torres A, Papaseit E, Pérez-Mañá C, Hladun O, Núñez-Montero M, de la Rosa G, Torrens M, Fuster D, Muga R, Farré M. Abuse Potential of Cathinones in Humans: A Systematic Review. J Clin Med. 2022 Feb 15; 11(4). PMID: 35207278; PMCID: PMC8878365; DOI: 10.3390/jcm11041004;

Zuluaga P, Teniente-Serra A, Fuster D, Quirant-Sánchez B, Hernandez-Rubio A, Martínez-Cáceres E, Muga R. Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change. J Clin Med. 2022 Jan 08; 11(2). PMID: 35054000; PMCID: PMC8780875; DOI: 10.3390/jcm11020305;

Showing 10 of 73 results. Show More

Fuster D, Garcia-Calvo X, Farré O, Zuluaga P, Bolao F, Leis A, Hernández-Rubio A, Rivas I, Muga R. Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder. J Clin Med. 2021 Aug 08; 10(16). PMID: 34441792; PMCID: PMC8396829; DOI: 10.3390/jcm10163496;

Fuster D, García-Calvo X, Zuluaga P, Bolao F, Muga R. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World J Gastroenterol. 2021 Jun 21; 27(23):3223-3237. PMID: 34163107; PMCID: PMC8218351; DOI: 10.3748/wjg.v27.i23.3223;

Fuster D, Studer J, Gmel G, Bertholet N. Correlates of the use of electronic devices to vape cannabis in a cohort of young Swiss male reporting current cannabis use. Eur J Public Health. 2021 04 24; 31(2):437-441. PMID: 33164041

Fuster D, Nunes D, Cheng DM, Saitz R, Samet JH. Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients. Viruses. 2021 04 21; 13(5).View Related Profiles.

Fuster, Daniel
Nunes, David
Cheng, Debbie
Samet, Jeffrey
Saitz, Richard

PMID: 33919027; PMCID: PMC8142976; DOI: 10.3390/v13050716;

Sanvisens A, Hernández-Rubio A, Zuluaga P, Fuster D, Papaseit E, Galan S, Farré M, Muga R. Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study. Front Pharmacol. 2021; 12:625610. PMID: 33679404; PMCID: PMC7930813; DOI: 10.3389/fphar.2021.625610;

Fuster D, So-Armah K, Cheng DM, Coleman SM, Gnatienko N, Lioznov D, Krupitsky EM, Freiberg MS, Samet JH. Lack of Association Between Recent Cannabis Use and Advanced Liver Fibrosis Among HIV-positive Heavy Drinkers. Curr HIV Res. 2021; 19(4):324-331.View Related Profiles.

Fuster, Daniel
Cheng, Debbie
Samet, Jeffrey
So-Armah, Kaku

PMID: 34061004; PMCID: PMC8597417; DOI: 10.2174/1570162X19666210519151320;

Sanvisens A, Zuluaga P, Short A, Rubio G, Gual A, Torrens M, Fuster D, Bolao F, Rodríguez de Fonseca F, Muga R. Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder. J Addict Med. 2021 Jan-Feb 01; 15(1):68-73. PMID: 32769772

Fuster D, García-Calvo X, Bolao F, Zuluaga P, Rocamora G, Hernández-Rubio A, Sanvisens A, Tor J, Muga R. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment. Drug Alcohol Depend. 2020 11 01; 216:108231. PMID: 32818911

Zuluaga P, Sanvisens A, Teniente-Serra A, El Ars O, Fuster D, Quirant-Sánchez B, Martínez-Cáceres E, Muga R. Loss of naive T lymphocytes is associated with advanced liver fibrosis in alcohol use disorder. Drug Alcohol Depend. 2020 Aug 01; 213:108046. PMID: 32485655

Fuster D, Muga R. Use of oipiods for chronic non-cancer pain. Reply. Med Clin (Barc). 2021 01 22; 156(2):98-99. PMID: 32156427

Fuster D. Cocaine Use: A Threat for the HIV-Infected Liver. J Womens Health (Larchmt). 2020 09; 29(9):1141-1142. PMID: 32027220

So-Armah K, Freiberg M, Cheng D, Lim JK, Gnatienko N, Patts G, Doyle M, Fuster D, Lioznov D, Krupitsky E, Samet J. Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption - an observational cross-sectional study. BMC Gastroenterol. 2019 Dec 31; 20(1):1.View Related Profiles.

Fuster, Daniel
Cheng, Debbie
Samet, Jeffrey
So-Armah, Kaku

PMID: 31892306; PMCID: PMC6938606; DOI: 10.1186/s12876-019-1136-4;

García-Calvo X, Bolao F, Sanvisens A, Zuluaga P, Tor J, Muga R, Fuster D. Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment. Alcohol Clin Exp Res. 2020 01; 44(1):152-158. PMID: 31797394

Fuster D, Gelberg L. Community Screening, Identification, and Referral to Primary Care, for Hepatitis C, B, and HIV Among Homeless Persons in Los Angeles. J Community Health. 2019 12; 44(6):1044-1054. PMID: 31127412

Barocas JA, So-Armah K, Cheng DM, Lioznov D, Baum M, Gallagher K, Fuster D, Gnatienko N, Krupitsky E, Freiberg MS, Samet JH. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia. PLoS One. 2019; 14(6):e0218852.View Related Profiles.

Fuster, Daniel
Cheng, Debbie
Samet, Jeffrey
Barocas, Joshua
So-Armah, Kaku

PMID: 31246992; PMCID: PMC6597160; DOI: 10.1371/journal.pone.0218852;

Fuster D, Samet JH. Alcohol Use in Patients with Chronic Liver Disease. N Engl J Med. 2018 12 27; 379(26):2579.View Related Profiles.

Fuster, Daniel
Samet, Jeffrey

PMID: 30586530

Fuster D, Samet JH. Alcohol Use in Patients with Chronic Liver Disease. N Engl J Med. 2018 09 27; 379(13):1251-1261.View Related Profiles.

Fuster, Daniel
Samet, Jeffrey

PMID: 30257164

Demir OM, Candilio L, Fuster D, Muga R, Barbaro G, Colombo A, Azzalini L. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol. 2018 Aug 15; 265:195-203. PMID: 29885686

Muga R, Sanvisens A, Jarrin I, Fuster D, Bolao F, Tor J, Muñoz A. Hepatitis C infection substantially reduces survival of alcohol-dependent patients. Clin Epidemiol. 2018; 10:897-905. PMID: 30123002; PMCID: PMC6078082; DOI: 10.2147/CLEP.S162308;

Fuster D, Garcia-Calvo X, Zuluaga P, Rivas I, Sanvisens A, Tor J, Muga R. Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. Drug Alcohol Depend. 2018 09 01; 190:195-199. PMID: 30048873

Fuster D, Muga R. The opioid crisis. Med Clin (Barc). 2018 12 21; 151(12):487-488. PMID: 29779572

Sanvisens A, Zuluaga P, Pineda M, Fuster D, Bolao F, Juncà J, Tor J, Muga R. Folate deficiency in patients seeking treatment of alcohol use disorder. Drug Alcohol Depend. 2017 Nov 01; 180:417-422. PMID: 28988003

Sanvisens A, Zuluaga P, Fuster D, Rivas I, Tor J, Marcos M, Chamorro AJ, Muga R. Long-Term Mortality of Patients with an Alcohol-Related Wernicke-Korsakoff Syndrome. Alcohol Alcohol. 2017 Jul 01; 52(4):466-471. PMID: 28340112; DOI: 10.1093/alcalc/agx013;

Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Farré M, Tor J, Muga R. Cannabis as Secondary Drug Is Not Associated With a Greater Risk of Death in Patients With Opiate, Cocaine, or Alcohol Dependence. J Addict Med. 2017 Jan/Feb; 11(1):34-39. PMID: 27753720; DOI: 10.1097/ADM.0000000000000266;

Fuster D, Sanvisens A, Bolao F, Rivas I, Tor J, Muga R. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol. 2016 Nov 08; 8(31):1295-1308. PMID: 27872681; PMCID: PMC5099582; DOI: 10.4254/wjh.v8.i31.1295;

Zuluaga P, Sanvisens A, Teniente A, Fuster D, Tor J, Martínez-Cáceres E, Muga R. Wide array of T-cell subpopulation alterations in patients with alcohol use disorders. Drug Alcohol Depend. 2016 May 1; 162:124-9. PMID: 27038675; DOI: 10.1016/j.drugalcdep.2016.02.046;

Fuster D, Cheng DM, Wang N, Bernstein JA, Palfai TP, Alford DP, Samet JH, Saitz R. Brief intervention for daily marijuana users identified by screening in primary care: A subgroup analysis of the ASPIRE randomized clinical trial. Subst Abus. 2016 Apr-Jun; 37(2):336-42.View Related Profiles.

Fuster, Daniel
Alford, Daniel
Cheng, Debbie
Samet, Jeffrey
Bernstein, Judith
Saitz, Richard

PMID: 26453188; PMCID: PMC4826635; DOI: 10.1080/08897077.2015.1075932;

Muga R, Zuluaga P, Sanvisens A, Rivas I, Fuster D, Bolao F, Tor J. Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon. Adicciones. 2015 Jun 17; 27(2):141-9. PMID: 26132303

Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Tor J, Muga R. Markers of inflammation and mortality in a cohort of patients with alcohol dependence. Medicine (Baltimore). 2015 Mar; 94(10):e607. PMID: 25761182; PMCID: PMC4602466; DOI: 10.1097/MD.0000000000000607;

Muga R, Rivas I, Faure E, Fuster D, Zuluaga P, Rubio M, Muñoz T, Torrens M, Tor J, Sanvisens A. Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study. BMC Infect Dis. 2014; 14:504. PMID: 25231321; PMCID: PMC4261781; DOI: 10.1186/1471-2334-14-504;

Fuster D, Sanvisens A, Bolao F, Serra I, Rivas I, Tor J, Muga R. Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients. J Viral Hepat. 2015 Jan; 22(1):18-24. PMID: 25131721; DOI: 10.1111/jvh.12290;

Fuster D, Cheng DM, Quinn EK, Armah KA, Saitz R, Freiberg MS, Samet JH, Tsui JI. Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems. AIDS. 2014 Apr 24; 28(7):1059-64.View Related Profiles.

Fuster, Daniel
Cheng, Debbie
Samet, Jeffrey
Tsui, Judith
So-Armah, Kaku
Saitz, Richard

PMID: 24401638; PMCID: PMC4105144; DOI: 10.1097/QAD.0000000000000184;

Fuster D, Samet JH, Saitz R. Marijuana use and health in primary care. J Gen Intern Med. 2014 Feb; 29(2):282.View Related Profiles.

Fuster, Daniel
Samet, Jeffrey
Saitz, Richard

PMID: 24234396; PMCID: PMC3912276; DOI: 10.1007/s11606-013-2705-9;

Sanvisens A, Vallecillo G, Bolao F, Rivas I, Fonseca F, Fuster D, Torrens M, Pérez-Hoyos S, Pujol R, Tor J, Muga R. Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain. Drug Alcohol Depend. 2014 Mar 1; 136:115-20. PMID: 24485061; DOI: 10.1016/j.drugalcdep.2013.12.022;

Fuster D, Cheng DM, Quinn EK, Nunes D, Saitz R, Samet JH, Tsui JI. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. Addiction. 2014 Jan; 109(1):62-70.View Related Profiles.

Fuster, Daniel
Nunes, David
Cheng, Debbie
Samet, Jeffrey
Tsui, Judith
Saitz, Richard

PMID: 24112091; PMCID: PMC3947001; DOI: 10.1111/add.12367;

Fuster D, Cheng DM, Allensworth-Davies D, Palfai TP, Samet JH, Saitz R. No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use. J Gen Intern Med. 2014 Jan; 29(1):133-9.View Related Profiles.

Fuster, Daniel
Cheng, Debbie
Samet, Jeffrey
Saitz, Richard

PMID: 24048656; PMCID: PMC3889953; DOI: 10.1007/s11606-013-2605-z;

Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res Hum Retroviruses. 2013 Aug; 29(8):1110-6.View Related Profiles.

Fuster, Daniel
Nunes, David
Cheng, Debbie
Samet, Jeffrey
Tsui, Judith
So-Armah, Kaku

PMID: 23601055; PMCID: PMC3715787; DOI: 10.1089/AID.2012.0348;

Fuster D, Tsui JI, Cheng DM, Quinn EK, Bridden C, Nunes D, Libman H, Saitz R, Samet JH. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection. Alcohol Clin Exp Res. 2013 Sep; 37(9):1527-35.View Related Profiles.

Bridden, Carly
Fuster, Daniel
Nunes, David
Cheng, Debbie
Samet, Jeffrey
Tsui, Judith
Saitz, Richard

PMID: 23647488; PMCID: PMC3758457; DOI: 10.1111/acer.12129;

Sanvisens A, Rivas I, Faure E, Muñoz T, Rubio M, Fuster D, Tor J, Muga R. [Characteristics of heroin dependent patients admitted to a methadone treatment program]. Med Clin (Barc). 2014 Jan 21; 142(2):53-8. PMID: 23337454; DOI: 10.1016/j.medcli.2012.10.023;

Rivas I, Sanvisens A, Bolao F, Fuster D, Tor J, Pujol R, Torrens M, Rey-Joly C, Muga R. Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E221-7. PMID: 23320801; DOI: 10.1111/j.1530-0277.2012.01861.x;

Muga R, Sanvisens A, Fuster D, Tor J, Martínez E, Pérez-Hoyos S, Muñoz A. Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One. 2012; 7(10):e46810. PMID: 23056462; PMCID: PMC3467291; DOI: 10.1371/journal.pone.0046810;

Fuster D, Tor J, Rey-Joly C, Muga R. [Pathogenic interactions between alcohol and hepatitis C]. Med Clin (Barc). 2012 May 19; 138(14):627-32. PMID: 21696783; DOI: 10.1016/j.medcli.2011.04.019;

Sanvisens A, Fuster D, Serra I, Tor J, Tural C, Rey-Joly C, Muga R. Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users. Curr HIV Res. 2011 Jun; 9(4):256-62. PMID: 21675942; DOI: 10.2174/157016211796320298;

Rosón B, Monte R, Gamallo R, Puerta R, Zapatero A, Fernández-Solá J, Pastor I, Girón JA, Laso J. Prevalence and routine assessment of unhealthy alcohol use in hospitalized patients. Eur J Intern Med. 2010 Oct; 21(5):458-64. PMID: 20816605; DOI: 10.1016/j.ejim.2010.04.006;

Rivas I, Martinez E, Sanvisens A, Bolao F, Tor J, Torrens M, Pujol R, Fuster D, Rey-Joly C, Muñoz A, Muga R. Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 1987-2006. Drug Alcohol Depend. 2010 Aug 1; 110(3):234-9. PMID: 20456873; DOI: 10.1016/j.drugalcdep.2010.03.005;

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl. 2009 Sep; 15(9):1133-41. PMID: 19718643; DOI: 10.1002/lt.21735;

Fuster D, Sierra A, Ayuso JR, Poveda A, Cubedo R, Casado A, Martínez-Trufero J, López-Pousa A, Garcia Del Muro X, Maurel J. Correlation between spiral CT and PET in patients with advanced GIST refractory to high-dose imatinib: A GEIS study. J Clin Oncol. 2009 May 20; 27(15_suppl):10553. PMID: 27963949

Langohr K, Sanvisens A, Fuster D, Tor J, Serra I, Rey-Joly C, Rivas I, Muga R. Liver enzyme alterations in HCV-monoinfected and HCV/HIV-coinfected patients. Open AIDS J. 2008; 2:82-8. PMID: 19274066; PMCID: PMC2627513; DOI: 10.2174/1874613600802010082;

Miro JM, Aguero F, Laguno M, Tuset M, Cervera C, Moreno A, Garcia-Valdecasas JC, Rimola A. Liver transplantation in HIV/hepatitis co-infection. J HIV Ther. 2007 Mar; 12(1):24-35. PMID: 17589393

Fumaz CR, Muñoz-Moreno JA, Ballesteros AL, Paredes R, Ferrer MJ, Salas A, Fuster D, Masmitjà E, Pérez-Alvarez N, Gómez G, Tural C, Clotet B. Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients. AIDS Care. 2007 Jan; 19(1):138-45. PMID: 17129869

Solà R, Galeras JA, Montoliu S, Tural C, Force L, Torra S, Montull S, Castro ER, Coll S, Fuster D, Barrufet P, Sirera G, Giménez MD, Clotet B, Planas R. Poor response to hepatitis C virus (HCV) therapy in HIV- and HCV-coinfected patients is not due to lower adherence to treatment. AIDS Res Hum Retroviruses. 2006 May; 22(5):393-400. PMID: 16706615

Fuster D, Planas R, Gonzalez J, Force L, Cervantes M, Vilaró J, Roget M, García I, Pedrol E, Tor J, Ballesteros AL, Salas A, Sirera G, Videla S, Clotet B, Tural C. Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response. Antivir Ther. 2006; 11(4):473-82. PMID: 16856621

Fuster D, Clotet B. Review of atazanavir: a novel HIV protease inhibitor. Expert Opin Pharmacother. 2005 Aug; 6(9):1565-72. PMID: 16086644

Ballesteros AL, Fuster D, Planas R, Clotet B, Tural C. Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients. J Antimicrob Chemother. 2005 Jun; 55(6):824-7. PMID: 15886264

Fuster D, Huertas JA, Gómez G, Solà R, González García J, Vilaró J, Pedrol E, Force L, Tor J, Sirera G, Videla S, Planas R, Clotet B, Tural C. Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy. Antivir Ther. 2005; 10(7):841-7. PMID: 16312180

Ballesteros AL, Miró O, López S, Fuster D, Videla S, Martínez E, Garrabou G, Salas A, Côté H, Tor J, Rey-Joly C, Planas R, Clotet B, Tural C. Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both. Antivir Ther. 2004 Dec; 9(6):969-77. PMID: 15651755

Fuster D, Planas R, Muga R, Ballesteros AL, Santos J, Tor J, Sirera G, Guardiola H, Salas A, Cabré E, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Tural C. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy. AIDS Res Hum Retroviruses. 2004 Dec; 20(12):1293-7. PMID: 15650421

Lloveras B, Monzo M, Colomer R, Llombart A, Ramos M, Mayordomo JI, Fuster D, Alba E. Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer patients. J Clin Oncol. 2004 Jul 15; 22(14_suppl):507. PMID: 28016103

Ibeas R, Monzo M, Moreno I, Hernandez R, Campayo M, Pie J, Fuster D, Torres G, Alcaide A, Jove J. Cytidine Deaminase (CD) and Dihydropyrimidine Dehydrogenase (DPD) single nucleotide polymorphisms (SNPs) in capecitabine-treated colorectal cancer (CRC). J Clin Oncol. 2004 Jul 15; 22(14_suppl):3662. PMID: 28014652

Carles J, Monzo M, Artells R, Amat M, Foro P, Fuster D, Alameda F, Sanchez JM, Fontane J, Sanchez J. XPC, XPD/ERCC2, UMPS, CYP1b1 and XRCC5, single nucleotide polymorphisms (SNPs) in head and neck cancer. J Clin Oncol. 2004 Jul 15; 22(14_suppl):5588. PMID: 28014072

Ballesteros AL, Franco S, Fuster D, Planas R, Martínez MA, Acosta L, Sirera G, Salas A, Tor J, Rey-Joly C, Clotet B, Tural C. Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches. AIDS. 2004 Jan 2; 18(1):59-66. PMID: 15090830

Fuster D, Clotet B. Chronic HCV infection in HIV-positive patients: a new challenge. J Int Assoc Physicians AIDS Care (Chic). 2003 Apr-Jun; 2(2):56-8. PMID: 12961758

Tural C, Fuster D, Tor J, Ojanguren I, Sirera G, Ballesteros A, Lasanta JA, Planas R, Rey-Joly C, Clotet B. Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients. J Viral Hepat. 2003 Mar; 10(2):118-25. PMID: 12614468

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 73 publications over 22 distinct years, with a maximum of 7 publications in 2021